Alaunos Therapeutics Inc. (NASDAQ:TCRT) went down by -6.54% from its latest closing price compared to the recent 1-year high of $2.94. The company’s stock price has collected 5.04% of gains in the last five trading sessions.
Is It Worth Investing in Alaunos Therapeutics Inc. (NASDAQ :TCRT) Right Now?
Plus, the 36-month beta value for TCRT is at 0.88. Opinions of the stock are interesting as 4 analysts out of 6 who provided ratings for Alaunos Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $4.30, which is $3.49 above the current price. TCRT currently public float of 193.32M and currently shorts hold a 18.60% ratio of that float. Today, the average trading volume of TCRT was 2.98M shares.
TCRT’s Market Performance
TCRT stocks went up by 5.04% for the week, with a monthly jump of 67.96% and a quarterly performance of 10.72%, while its annual performance rate touched -69.24%. The volatility ratio for the week stands at 13.06% while the volatility levels for the past 30 days are set at 16.74% for Alaunos Therapeutics Inc. The simple moving average for the period of the last 20 days is 24.51% for TCRT stocks with a simple moving average of -24.95% for the last 200 days.
TCRT Trading at 40.61% from the 50-Day Moving Average
After a stumble in the market that brought TCRT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.49% of loss for the given period.
Volatility was left at 16.74%, however, over the last 30 days, the volatility rate increased by 13.06%, as shares surge +62.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +45.41% upper at present.
During the last 5 trading sessions, TCRT rose by +5.04%, which changed the moving average for the period of 200-days by -54.30% in comparison to the 20-day moving average, which settled at $0.6652. In addition, Alaunos Therapeutics Inc. saw -25.79% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TCRT
Current profitability levels for the company are sitting at:
- -18379.90 for the present operating margin
The net margin for Alaunos Therapeutics Inc. stands at -19786.68. Equity return is now at value -101.40, with -66.90 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.91.